fluticasone furoate inhaled
Selected indexed studies
- Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis. (Adv Ther, 2022) [PMID:35849317]
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. (N Engl J Med, 2018) [PMID:29668352]
- Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19. (N Engl J Med, 2023) [PMID:37733308]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease. (2025) pubmed
- Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT. (2023) pubmed
- Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy. (2025) pubmed
- Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis. (2022) pubmed
- Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease. (2020) pubmed
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. (2018) pubmed
- FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease. (2017) pubmed
- Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19. (2023) pubmed
- Fluticasone, Inhaled. (2006) pubmed
- Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management. (2023) pubmed